Kidney Function Test Market Research Report ‚Äď Forecast to 2030

Global Kidney Function Test Market Research Report, by Test (Blood Test, Imaging Test, Urine Test), Product (Dipsticks, Disposables, Reagent), End-User (Hospitals & Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers) - Global Forecast Till 2030

ID: MRFR/LS/4712-HCR | 100 Pages | Author: Rahul Gotadki | February 2024         

Kidney Function Test Market Speak to Analyst Request a Free Sample

Kidney Function Test Market Overview:


The Kidney Function Test Market is anticipated to reach USD 795.4 Million by 2030 at 6.20% CAGR during the forecast period 2022-2030. Kidney function tests are carried out to evaluate the functioning of kidneys. Because of the increased frequency of chronic renal disease, the market of kidney function test is predicted to rise. 


Chronic Kidney Disease affects 30 million individuals in the United States, according to the Centers for Disease Control and Prevention (CDC) (CKD). Other important factors driving market expansion include an increase in alcohol use, a shift to a sedentary lifestyle, rising diabetes prevalence, rising obesity, and rising cardiovascular disease prevalence.


Diabetes is linked to kidney disease because it damages the blood arteries in the kidneys, causing the kidneys to malfunction. Such circumstances raise the risk of renal disease. According to the Centers for Disease Control and Prevention, End-Stage Renal Disease affected 44 percent of diabetes patients in 2017. (ESRD)


The market is anticipated to expand significantly due to numerous factors, including rising government efforts, rising R&D activities, rising investments by industry participants, and rising prevalence of renal disorders. The market for kidney function tests is anticipated to be driven by the rising prevalence of acute kidney injury (AKI) and related chronic kidney disease (CKD) in the years to come. The industry is anticipated to benefit from the growing burden of these diseases on the population. Additionally, several factors, such as an increase in chronic kidney disease, an increase in the prevalence of underlying illnesses like diabetes and hypertension that can cause kidney disorders, an increase in awareness of diagnostic procedures for kidney function, and technological advancements in the field of kidney diagnostics are all contributing to the market's growth.


Thus, the rise in the incidence of CKD diseases and the burden of the disease are expected to drive the market growth for kidney function tests soon. Kidney function tests are fast urine and blood exams that help identify and evaluate kidney problems. Urine testing, which has become more common, is one of the first procedures that can be used to evaluate the condition of the kidneys. A dearth of knowledge about kidney function tests could hamper the market revenue. Three months must have passed for structural abnormalities and persistent renal function to be considered CKD. The increased use of digital urinalysis also reflects the rise in popularity of home diagnostics, thus propelling market expansion.


Additionally, growing R&D projects to create novel products are anticipated to accelerate the expansion of the kidney function substantially tests market over the projected year. An important factor expected to benefit the market is the rise in the prevalence and mortality of chronic renal disorders. Results of renal function tests are very important in assessing kidney functionality. As a result, chronic kidney disease's incidence and fatality rates are expected to rise, which will drive the demand for kidney function tests and propel the market. Furthermore, technical developments connected to kidney function testing will likely present attractive prospects within the anticipated timeframe.


Key players

Some of the key players in the global kidney function test market are: 



  • Urit Medical,

  • Sysmex Corporation, 

  • Siemens Healthcare GmbH (Germany), 

  • F. Hoffmann-La Roche Ltd., 

  • Randox Laboratories, 

  • Opti Medical, 

  • Nova Biomedical

  • Beckman Coulter, 

  • ARKRAY, Inc., 

  • Acon Laboratories, 

  • Abbott, 

  • Cook Medical, 

  • 77 Elektronika, 

  • Medical Care (Germany), 

  • Baxter (U.S.), 

  • Boston Scientific (U.S.), and others.


Kidney Function Test Market Segment Insights


The global market of kidney function test is segmented on the basis of tests, product, and end-user. 

 

Kidney Function Test Insights


The kidney function test market, by tests, is categorized into blood tests, imaging tests, urine tests balloons, and kidney biopsy. The blood tests category includes serum creatinine, Glomerular Filtration Rate (GFR), and Blood Urea Nitrogen (BUN). The imaging tests segment includes ultrasound and CT scan. The urine tests category includes urinalysis, urine protein, microalbuminuria, and creatinine clearance. 


Kidney Function Test Product Insights


The product segment is segmented into dipsticks, disposables, and reagents. 


Kidney Function Test End-User Insights


On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic laboratories, ambulatory surgical centers, academic research laboratories, and others.  


Kidney Function Test Regional Insights


On the basis of region, the global market of kidney function test is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the U.S. and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the U.K., Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


News:


According to a new study published today in Circulation, the premier journal of the American Heart Association, patients with Type 2 diabetes and renal disease may be able to forecast their risk of developing progressive heart and kidney disease using a straightforward blood test. Medical experts frequently measure biomarkers to detect, identify, or treat certain diseases. According to earlier studies, some biomarker concentrations may be able to predict the initiation and progression of cardiovascular events in Type 2 diabetics as well as the development of chronic renal disease. To determine the effects of canagliflozin on concentrations of the four biomarkers from the start of the study, the researchers examined biomarker data from the blood samples of 2,627 participants in the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) trial. Additionally, they looked at each biomarker's predictive value for different renal disorders and the chance of passing away from cardiovascular or kidney disease. Patients were divided into low-risk, medium-risk, and high-risk groups.

 


Regional Market Summary


The kidney function test market is dominated by North America owing to the rising prevalence of chronic kidney diseases. According to the Centers for Disease Control and Prevention in 2017, 15% of the Americans are estimated to have chronic kidney diseases. The presence of major market players such as Baxter, Cook Medical, C. R. Bard, Inc., and others within the region, influences the market growth. Other factors such as increasing healthcare expenditure and increasing obesity within the population drive the market growth in this region.


It is estimated that Europe stood second in the global market of kidney function test owing to the increasing prevalence of chronic kidney diseases. According to the European Renal Association and the European Dialysis and Transplant Association (ERA-EDTA), 70 million people in Europe suffer from some or the other type of kidney disease. Thus, the increasing prevalence of Chronic Kidney Diseases (CKD) in this region influences the growth of the market in this region.


Asia Pacific was projected to be the fastest growing region for the global kidney function test market in 2017. The market is expected to witness growth owing to the rising prevalence of diabetes and growing geriatric population. Old age is associated with loss of kidney function. According to The Asian Development Bank (ADB), the geriatric population in Asia is estimated to reach 923 million by 2050. This provides favorable background for the market to grow in the Asia Pacific region.


The Middle East and Africa holds the least share in the global kidney function test market due to the presence of stringent government policies, low gross national income, and poor health planning and therapeutic measures. However, the market is expected to witness growth due to awareness of advances in therapeutic and preventive measures in the Middle East. Other growth factors such as hypertension, smoking, and high cholesterol within the region contribute to the market growth.


Global Kidney Function Test Market Share (%), by Region


 Kidney Function Test Market Share


Sources: Centers for Disease Control and Prevention, the National Institutes of Health, National Kidney Foundation, National Chronic Kidney Disease

Recent Development


Apellis will present data from eight patients in its current phase two clinical study with the therapeutic candidate APL-2 in the complement 3 glomerulopathy (C3G) group. The protein C3 is degraded by a hyperactive immune system in C3G, resulting in fragments being stuck in the kidney. Inflammation and organ damage ensue as a result of the accumulation. According to the firm, 30 to 50 percent of C3G patients will have a renal failure within ten years after being diagnosed. Apellis' APL-2 aims to prevent the body from targeting the C3 protein, which is a mediator in the complement pathway of the immune system."


Reata's hot run might continue during Renal Week, with presentations concentrating on bardoxolone methyl, the company's top pipeline candidate, and its influence on kidney events and cardiovascular safety. The business repurchased global rights to certain of its therapeutic candidates from AbbVie (ABBV -6.03 percent) and provided encouraging clinical data in a study of omaveloxolone for Friedreich's ataxia treatment. Since those results were revealed, Reata's stock has soared by 70%, and results from its phase-three clinical study with bardoxolone methyl for Alport syndrome are due before the end of the year.


Research Methodology


Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.




  • Primary Research




Extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.




  • Secondary Research




Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and commercial study of the global kidney function test market. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, international organization of chemical manufacturers, some paid databases, and many others.

Report Scope:

Report Attribute/Metric Details
  Market Size   USD 795.4 Million
  CAGR   6.20%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Test, Product, End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Urit Medical, Sysmex Corporation, Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd., Randox Laboratories, Opti Medical, Nova Biomedical, Beckman Coulter, ARKRAY, Inc., Acon Laboratories, Abbott, Cook Medical, 77 Elektronika, Medical Care (Germany), Baxter (U.S.), Boston Scientific (U.S.)
  Key Market Opportunities   Joint ventures, strategic alliances, mergers and acquisitions and new product developments
  Key Market Drivers ·  Increasing healthcare expenditure and increasing obesity within the population ·  Growing geriatric population




Frequently Asked Questions (FAQ) :

The global kidney function test market has the opportunity to attain a CAGR of 6.20% during the forecast period of 2022 to 2030.

The global kidney function test market can find hurdles in the shape of the high cost of diagnostic procedures, infections, and huge initial investments.

End user industries like diagnostic laboratories, hospitals & clinics, academic research laboratories, ambulatory surgical centers, and others can trigger growth for the kidney function test market.

North America would have a dominating position in the global kidney function test market.

The Asia Pacific region would be the fastest in terms of growth among all kidney function test market regions.

Key Questions Answered

  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players‚Äô financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample

Why Choose Market Research Future?

  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid